Abstract
The combination of type 1 diabetes and bulimia nervosa has been referred to as ‘diabulimia’. The prognosis is poorer in subjects with comorbid disorder than those with isolated bulimia nervosa. Collaborative, integrated care is needed in the assessment and treatment of patients. In this review article we provide a formulation merging both the transdiagnostic and dual pathway models and discuss the latest evidence‐based management for patients with coexisting diagnoses.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
